H. Alva

A pervasive mechanism for analgesia: Activation of GIRK2 channels

Yuri A. Blednov, Markus Stoffel, H. Alva et al. · Proceedings of the National Academy of Sciences · 2002 · 165 citations · Full text

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Deletion of the α1 or β2 Subunit of GABAAReceptors Reduces Actions of Alcohol and Other Drugs

Yuri A. Blednov, Sungwon Jung, H. Alva et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 116 citations

GABAA Receptor α1 and β2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol

Yuri A. Blednov, Danielle Walker, H. Alva et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 100 citations

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text